Loading…
Enlivex Ltd. is projected to rise to $1.07 by 2027, a +37% move from its current price of $0.782. ENLV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7508 | $0.7818 | $0.8142 | -0.02% |
| May 30 | $0.7381 | $0.7816 | $0.8277 | -0.05% |
| May 31 | $0.7285 | $0.7815 | $0.8383 | -0.07% |
| Jun 1 | $0.7205 | $0.7813 | $0.8472 | -0.09% |
| Jun 2 | $0.7134 | $0.7811 | $0.8552 | -0.11% |
| Jun 3 | $0.7071 | $0.7809 | $0.8624 | -0.14% |
| Jun 4 | $0.7014 | $0.7808 | $0.8691 | -0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7014 | $0.7808 | $0.8691 | -0.16% |
| Week 2 | $0.6699 | $0.7795 | $0.9071 | -0.32% |
| Week 3 | $0.6464 | $0.7783 | $0.9371 | -0.47% |
| Week 4 | $0.6271 | $0.7771 | $0.9629 | -0.63% |
| Week 5 | $0.6104 | $0.7758 | $0.986 | -0.79% |
| Week 6 | $0.5957 | $0.7746 | $1.01 | -0.95% |
| Week 7 | $0.5824 | $0.7734 | $1.03 | -1.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Enlivex Ltd. is a clinical-stage macrophage reprogramming immunotherapy company in Israel. It operates with subsidiaries and offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis.
The company develops AllocetraTM intra-articular injection for knee osteoarthritis, which is in a phase 1/2 trial, and AllocetraTM intra-articular treatment for osteoarthritis of the temporomandibular joint (TMJ); it also develops Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2.
Enlivex Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel. It was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026.
Enlivex Ltd. (ENLV) is the equity instrument for the company. Current price is $0.782 with a market cap of $188.5M, and it ranks 3833.
The price outlook for ENLV shows a neutral near-term stance in 2026, with a forecast min of $0.684, avg of $0.782, and max of $1.18; sentiment is NEUTRAL and ROI is 0.
From 2027 onward, the forecast suggests a bullish trajectory with rising averages: 2027 avg $1.07, 2028 avg $1.01, 2029 avg $1.15, 2030 avg $1.16, 2031 avg $1.04, 2032 avg $1.31, 2033 avg $1.59, 2034 avg $1.76, 2035 avg $1.90, 2040 avg $2.61, and 2050 avg $4.29, all carrying bullish sentiment and positive ROI progression.
A major floor 27.4% below — a decisive break under it would weaken the trend.
The nearest floor, 12.5% below — buyers have tended to step in here.
The nearest ceiling, 16.0% above — a clean break opens room to run.
A major ceiling 53.5% above — clearing it would confirm fresh momentum.
Key ENLV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENLV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7216 | Buy | $0.7312 | Buy |
| MA 10 | $0.7195 | Buy | $0.7334 | Buy |
| MA 20 | $0.7601 | Buy | $0.7628 | Buy |
| MA 50 | $0.8742 | Sell | $0.8485 | Sell |
| MA 100 | $0.9642 | Sell | $0.9186 | Sell |
| MA 200 | $1.01 | Sell | $0.9923 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.42 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 31.90 | Neutral |
| Williams %R (14) | -17.65 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 1.56 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 82.35 | Sell |
| TRIX (15) | -0.88 | Sell |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 55.86 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 0.73 | Buy |
| ADX (14) | 24.22 | Sell |
| ATR (14) | 0.03 | Info |
Near-term technical picture is NEUTRAL with RSI(14) at 50. The 50-day simple moving average is $0.8742 and the 200-day simple moving average is $1.01.
The stock trades within a 30-day range of $0.5987 to $1.02. Immediate support is at $0.684 and resistance at $0.907. Annualized volatility is 80%, indicating elevated near-term price swings.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.684 | $0.782 | $1.18 | 0% | Neutral | |
| $0.8108 | $1.07 | $1.52 | +37% | Bullish | |
| $0.7329 | $1.01 | $1.51 | +29% | Bullish | |
| $0.8062 | $1.15 | $1.79 | +48% | Bullish | |
| $0.7834 | $1.16 | $1.86 | +48% | Bullish | |
| $0.6807 | $1.04 | $1.71 | +33% | Bullish | |
| $0.8346 | $1.31 | $2.21 | +67% | Bullish | |
| $0.9848 | $1.59 | $2.74 | +103% | Bullish | |
| $1.06 | $1.76 | $3.11 | +125% | Bullish | |
| $1.12 | $1.90 | $3.42 | +143% | Bullish | |
| $1.37 | $2.61 | $5.09 | +234% | Bullish | |
| $1.93 | $4.29 | $9.38 | +449% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.684 | $0.782 | $0.928 | +0.00% |
| June 2026 | $0.6615 | $0.7851 | $0.96 | +0.40% |
| July 2026 | $0.6373 | $0.766 | $0.9552 | -2.43% |
| August 2026 | $0.6631 | $0.805 | $1.02 | +5.09% |
| September 2026 | $0.6948 | $0.8505 | $1.09 | +5.65% |
| October 2026 | $0.684 | $0.8435 | $1.09 | -0.82% |
| November 2026 | $0.6822 | $0.8471 | $1.11 | +0.42% |
| December 2026 | $0.7134 | $0.8915 | $1.18 | +5.25% |
Click any year to see its month-by-month ENLV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ENLV could reach as high as $1.18, with a base case around $0.782 and support toward $0.684 — roughly 0% from $0.782. Price action looks broadly range-bound.
Expect ENLV to range from $0.8108 to $1.52 through 2027. The $1.07 average target implies a +37% move from current prices. That is up +37% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ENLV price prediction for 2028 points to an average of $1.01 (low $0.7329, high $1.51) — a potential gain of +29% on today's $0.782. Momentum favours further upside here.
In 2029, ENLV is projected to trade between $0.8062 and $1.79, averaging $1.15 — a potential gain of +48% from today's $0.782. That is up +14% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Enlivex Ltd.'s 2030 outlook centres on $1.16, within a $0.7834 to $1.86 range. That is up 0% on the projected 2029 average. That marks a +48% change versus current levels. Momentum favours further upside here.
By 2031, ENLV could reach as high as $1.71, with a base case around $1.04 and support toward $0.6807 — roughly +33% from $0.782. Buyers look set to stay in control over this stretch.
Expect ENLV to range from $0.8346 to $2.21 through 2032. The $1.31 average target implies a +67% move from current prices. That is up +26% on the projected 2031 average. Momentum favours further upside here.
The ENLV price prediction for 2033 points to an average of $1.59 (low $0.9848, high $2.74) — a potential gain of +103% on today's $0.782. Buyers look set to stay in control over this stretch.
In 2034, ENLV is projected to trade between $1.06 and $3.11, averaging $1.76 — a potential gain of +125% from today's $0.782. That is up +11% on the projected 2033 average. Momentum favours further upside here.
Enlivex Ltd.'s 2035 outlook centres on $1.90, within a $1.12 to $3.42 range. That is up +8% on the projected 2034 average. That marks a +143% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ENLV could reach as high as $5.09, with a base case around $2.61 and support toward $1.37 — roughly +234% from $0.782. Momentum favours further upside here.
Expect ENLV to range from $1.93 to $9.38 through 2050. The $4.29 average target implies a +449% move from current prices. That is up +64% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENLV today (≈ 1,278.772379 ENLV) could be worth
$5,489.69
+$4,489.69 (+449%) by 2050 · US Dollar
Based on the average projected ENLV price of $4.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENLVwould be worth at today's price.
$1,000 invested in ENLV on May 27, 2025 (≈ 1,005.025121 ENLV) would be worth
$785.93
-$214.07 (-21.4%) today · 0.79× · US Dollar
Based on a ENLV entry price of $0.995 vs. today's $0.782.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.704 | $1,110.8 | +11.1% |
| 1 month ago | $0.882 | $886.62 | -11.3% |
| 3 months ago | $1.15 | $680 | -32.0% |
| 6 months ago | $0.97 | $806.19 | -19.4% |
| 1 year ago | $0.995 | $785.93 | -21.4% |
| All time (5.0y) ago | $9.96 | $78.51 | -92.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENLV forecast.
Our base-case forecast reaches $1.60 around 2034.
Implied market cap at $1.60: $385.68M
The multi-year forecast shows a bullish trajectory, with 2030 average at $1.16 (ROI 48.1) and 2040 average at $2.61 (ROI 233.9), and 2050 average at $4.29 (ROI 449). These years reflect a continued upside from the current level and a pathway to higher pricing in the horizon.
These are estimates, not guarantees. While the forecast depicts rising averages and bullish sentiment across several years, actual outcomes will depend on market conditions and the company’s ongoing development progress.
Tap a question to reveal the answer.
avg $1.16; min $0.7834; max $1.86; ROI 48.1; sentiment BULLISH.
Forecast shows NEUTRAL in 2026, then BULLISH from 2027 onward with multiple years showing double-digit ROI (e.g., 2027 37.2, 2035 142.7, 2050 449). These are estimates, not guarantees.
Forecast max in 2050 is $9.38 with ROI 449, implying reaching $5 is within the forecast range, though not guaranteed.
Current price $0.782; market cap $188.5M; rank 3833.
2040 avg $2.61; min $1.37; max $5.09; ROI 233.9; sentiment BULLISH.
Enlivex Ltd. Community Discussion
0Share your Enlivex Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.